Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

THOMAS W LEBLANC

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1790997989
CMS profile
308811
Location
DURHAM, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$177,085.90

99 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Celgene Corporation $97,792.99 40
AbbVie Inc. $30,961.66 21
Agios Pharmaceuticals, Inc. $24,708.38 18
AstraZeneca Pharmaceuticals LP $10,660.37 12
Astellas Pharma US Inc $5,450.00 1
Genentech USA, Inc. $3,300.00 2
PFIZER INC. $2,762.50 3
Acceleron Pharma, Inc. $1,000.00 1
BeiGene, Ltd. $450.00 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

99 matching records · $177,085.90 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 99 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 99.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Astellas Pharma US Inc $5,450.0012/22/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026718347879 CMS
Acceleron Pharma, Inc. $1,000.0012/18/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026712262857 CMS
AstraZeneca Pharmaceuticals LP $1,074.0012/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736421835 CMS
Celgene Corporation $2,625.0012/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753817149 CMS
Celgene Corporation $2,625.0012/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753817151 CMS
Agios Pharmaceuticals, Inc. $1,000.0012/16/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751966311 CMS
Celgene Corporation $2,625.0012/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753817153 CMS
AbbVie Inc. $2,550.0012/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979451 CMS
Agios Pharmaceuticals, Inc. $1,000.0012/03/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751969735 CMS
AbbVie Inc. $1,625.0012/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979447 CMS
AbbVie Inc. $2,550.0011/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979439 CMS
AbbVie Inc. $2,550.0011/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979443 CMS
Celgene Corporation $2,625.0011/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878047 CMS
Celgene Corporation $2,625.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878041 CMS
Celgene Corporation $3,966.0011/18/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878075 CMS
Agios Pharmaceuticals, Inc. $1,000.0011/17/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751963977 CMS
AstraZeneca Pharmaceuticals LP $268.5011/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735778827 CMS
AstraZeneca Pharmaceuticals LP $537.0011/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736356123 CMS
Celgene Corporation $2,625.0011/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878069 CMS
Celgene Corporation $2,625.0011/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753817155 CMS
Celgene Corporation $2,625.0011/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878063 CMS
AbbVie Inc. $1,950.0011/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979435 CMS
Genentech USA, Inc. $1,650.0010/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743122771 CMS
Celgene Corporation $2,625.0010/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878053 CMS
Celgene Corporation $5,224.0010/23/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878073 CMS
Celgene Corporation $2,625.0010/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878051 CMS
Celgene Corporation $2,625.0010/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878061 CMS
Celgene Corporation $2,625.0010/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878067 CMS
Celgene Corporation $2,625.0010/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878057 CMS
AbbVie Inc. $1,950.0010/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979431 CMS
Agios Pharmaceuticals, Inc. $1,000.0010/07/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751965111 CMS
Agios Pharmaceuticals, Inc. $4,500.0010/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751967593 CMS
Celgene Corporation $2,625.0009/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878045 CMS
Celgene Corporation $2,625.0009/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878007 CMS
Celgene Corporation $2,625.0009/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878019 CMS
Celgene Corporation $2,625.0009/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878003 CMS
AbbVie Inc. $1,950.0009/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979429 CMS
Celgene Corporation $2,625.0009/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878009 CMS
Celgene Corporation $2,625.0009/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878023 CMS
Celgene Corporation $1,500.0009/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727877995 CMS
Agios Pharmaceuticals, Inc. $1,000.0009/01/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751967461 CMS
Celgene Corporation $2,625.0008/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878013 CMS
Celgene Corporation $2,625.0008/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727878015 CMS
Celgene Corporation $11.2908/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727877991 CMS
Celgene Corporation $2,625.0008/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727877997 CMS
Genentech USA, Inc. $1,650.0008/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743122765 CMS
AstraZeneca Pharmaceuticals LP $1,074.0008/04/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735970959 CMS
AstraZeneca Pharmaceuticals LP $1,074.0007/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736182519 CMS
Celgene Corporation $3,000.0007/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727877985 CMS
AbbVie Inc. $650.0007/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721979425 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97,483.41 98
PY2020 $177,085.90 99
PY2021 $164,030.26 110
PY2022 $240,282.17 239
PY2023 $284,194.50 217
PY2024 $321,417.51 245
PY2025 $459,432.34 337

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
THOMAS W LEBLANC, NPI 1790997989. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1790997989.
APA 7
IndustryPayments. (2026). THOMAS W LEBLANC, NPI 1790997989 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1790997989
Bluebook
THOMAS W LEBLANC, NPI 1790997989, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1790997989.

Source: Centers for Medicare & Medicaid Services, Open Payments.